Cerium Oxide Nanoparticles (CeO2-NPs) are commonly used in polishing, engine enhancement agents and many other commercial products. Increased applications and accidental release have raised concerns on the potential impact of CeO2-NPs on the environment. Most previous studies focused on the short term effect of CeO2-NPs. Information is severely lacking on the long-term impact of CeO2-NPs at environmentally relevant concentrations. The main goal of the current dissertation was to investigate the chronic phytotoxicity of CeO2-NPs on two plant species, tomato (Solanum lycopersicum L.) and Turnip mustard (Brassica rapa L.) fast growing variety, and the physiological and biochemical responses of these two plant species to CeO2-NPs. Four specific objectives were established. The first objective was to investigate the effects of combined CeO2-NPs and TiO2-NPs exposure on tomato plant growth and oxidative stress. The second objective was to investigate the impact of a lifecycle exposure to CeO2-NPs on wild type tomato growth and fruit yield and to evaluate the transgenerational effects of CeO2-NPs exposure on plant growth and the oxidative stress of the second generation tomato seedlings. The third objective was to compare the influence of CeO2-NPs and bulk CeO2 particles on plant growth and oxidative stress of standard fast growing Brassica rapa. The final objective was to evaluate the risks of CeO2-NPs exposure over three generations on Brassica plant growth, oxidative stress and reproduction. The results suggested that firstly, CeO2-NPs pre-exposure at concentrations of 4 and 40 mg/kg dry soil followed by 1000 mg/L of TiO2-NPs post-treatment increased H2O2 content and antioxidant proteins activities compared with CeO2-NPs alone and TiO2-NPs alone, and reduced biomass of the tomato plants compared with CeO2-NPs alone. Secondly, irrigation of CeO2-NPs at concentrations up to 10 mg/L stimulated wild type tomato plant growth, but exposure to CeO2-NPs over a lifecycle harmed plant growth and induced higher H2O2 content in tomato seedlings of the second generation. Thirdly, bulk CeO2 exposure at irrigation concentrations of 10, and 100 mg/L were more beneficial for Brassica rapa plant growth than CeO2-NPs at equivalent concentrations. CeO2-NPs irrigation at 10 and 100 mg/L increased H2O2 content and antioxidant proteins activities than bulk CeO2 at equivalent concentrations. However, the mustard plants treated by CeO2-NPs or bulk CeO2 showed changes of H2O2 content in different growth stages, which illustrated that CeO2-NPs and the bulk counterpart induced the change of H2O2 content differently. Finally, irrigating mustard plants with 10 to 1000 mg/L CeO2-NPs over three generations resulted in an inhibited plant growth, stronger oxidative stress, less seed yield and poorer reproduction of offspring plants. To our knowledge, this is the first report on the chronic (multigenerational) effects of CeO2-NPs on plant growth and oxidative stress of tomato and mustard plants grown in soil.

Cerium oxide (ceria, CeOâ‚‚) is a rare earth oxide that has attracted wide-spread research interest because of its unique properties such as high mechanical strength, oxygen ion conductivity, oxygen storage capacity and autocatalytic property. In recent years, researchers have discovered that ceria nanoparticles (NPs) are capable of protecting cells from free radical induced damage. Interestingly, it was found that nanometer size (~ 5 nm) ceria can scavenge free radicals quite efficiently, thus acting as an anti-oxidant. This phenomenon has been explained based on the autocatalytic property of ceria NPs. Several methods have been developed for the synthesis of ceria NPs that include flame combustion, hydroxide co-precipitation, hydrothermal/solvothermal, microemulsion, sonochemical and microwave-assisted heating methods and sol-gel method. Ceria NPs synthesized by these methods are often highly aggregated. Furthermore, large scale synthesis of monodispersed CeOâ‚‚ NPs is quite challenging. Therefore it is desirable to synthesize ceria NPs in bulk quantity keeping its important properties intact, specifically free-radical scavenging property. The main goal of this study is therefore to synthesize ultra-small ([less than]5.0 nm), high quality monodispersed ceria NPs in large quantities. In this thesis work, I present a couple of room temperature techniques, dilute sodium hydroxide (NaOH) assisted and ethylenediamine (EN) assisted for the synthesis of nearly mono-dispersed, ultra-small ( < 5 nm) and water-dispersible ceria NPs. Morphology and particle size of the ceria NPs were investigated through high resolution transmission electron microscopy (HRTEM). The HRTEM analysis confirmed the formation of 3.0 ± 0.5 nm size and 2.5 ± 0.2 nm size highlycrystalline ceria NPs when synthesized using dilute NaOH and EN as solvents, respectively. The nanostructures were characterized by X-ray diffraction (XRD) studies to determine the crystal structure and phase purity of the products. The samples were also thoroughly characterized by X-ray photoelectron spectroscopy (XPS) to determine the oxidation state of cerium ions. The presence of the +3 and +4 oxidation states in the samples was also confirmed from the XPS analysis. The co-existence of these two oxidation states is necessary for their applications as free radical scavenger. The autocatalytic behaviors of the ceria NPs were investigated through a hydrogen peroxide test and monitored by UV-visible transmission spectroscopy.

Cerium oxide nanoparticles (CONPs) are being investigated for several anti-oxidant applications in medicine. One of their most promising applications is as a radioprotective drug, an area of research in need due to the severe side effects from radiation therapy. In this work, the potential of CONPs as a radioprotective drug is examined using four criteria: favorable biodistribution/pharmacokinetics, low toxicity, ability to protect normal tissue from radiation damage, and lack of protection of tumor. The mechanisms of action of CONPs are also studied. Biodistribution was determined in radiolabeled CONPs with surface coatings including citrate, dextran T10-amine (DT10-NH2), dextran T10-polyethylene glycol (DT10-PEG), dextran T10-sulfobetaine (DT10-SB) and poly(acrylic acid) (PAA), and compared to uncoated. 89Zr was incorporated into CONPs for positron emission tomography (PET) imaging and ex vivo tissue analysis in tumor bearing mice. Compared to uncoated [89Zr]CONPs, coated [89Zr]CONPs showed improved biodistribution, including significantly enhanced renal clearance of PAA- [89Zr]CONPs. The toxicity of CONPs was evaluated in vitro and in vivo, with low toxicity at therapeutic doses. After clinically mimetic radiation therapy, pre-treatment of mice with coated and uncoated CONPs showed greater than 50% reduction of cell death in normal colon tissue, comparable to the clinically available radioprotective drug amifostine. Tumor control after irradiation of spontaneous colon tumors was unchanged with PAA-CONP pre-treatment, while citrate, DT10-PEG, and uncoated CONP pre-treatment had slightly less tumor control. Xenograft tumors were irradiated after pH normalizing treatment with sodium bicarbonate and PAA-CONP pre-treatment. Treatment of these tumors showed slightly less tumor control than irradiation alone or PAA-CONP plus irradiation, demonstrating that the acidic pH of the tumor microenvironment may be the basis of preventing CONPs’ radioprotective properties in tumor. These studies show that, among the variations of CONPs tested, PAA-CONP shows the most promise for its good biodistribution and quick clearance, low toxicity, ability to protect normal tissue, and lack of protection of tumor, meeting all the criteria set forth for an ideal radioprotective drug. Further studies on the effects of pH on CONPs actions may further elucidate their mechanisms of action, advancing them as a candidate for use as a radioprotective drug during radiation therapy.

The ability of engineered cerium oxide nanoparticles to confer radioprotection was examined. Rat astrocytes were treated with cerium oxide nanoparticles to a final concentration of 10 nanomolar, irradiated with a single 10 Gy dose of ionizing radiation and cell death was evaluated by propidium iodine uptake at 24 and 48 hours after radiation insult. Treatment of rat astrocytes with nanoceria resulted in an approximate 3-fold decrease in radiation induced death. These results suggest that the nanoceria are conferring protection from radiation induced cell death. Further experiments with human cells were conducted. Human normal and tumor cells (MCF-7 and CRL8798) were treated with the same dosage of cerium oxide nanoparticles, irradiated and evaluated for cell survival. Treatment of normal cells (MCF-7) conferred nearly 99% protection from radiation-induced cell death while the same concentration of nanoceria showed almost no protection in tumor cells (CRL8798). TUNEL analysis results of similarly treated cells demonstrated that nanoceria reduced radiation-induced cell death by 3-fold in normal breast cells but not in MCF-7 tumor cell lines when cultured under the same conditions. We concluded that cerium oxide nanoparticles confer radioprotection in a normal human breast line (CRL 8798) but not in a human breast tumor line (MCF-7). It is hoped that the outcome of this study will guide future endeavors toward a better elucidation of the molecular pathways involved in the protection of cells with nanoceria against radiation-induced cell death, as well as the minimization of the bystander effect in radiation therapy.

Cerium oxide nanoparticles (CeO2 NPs)(nanoceria) have been shown to possess a substantial oxygen storage capacity via the interchangeable surface reduction and oxidation of cerium atoms, cycling between the Ce4+ and Ce3+ redox states. Reduction of Ce4+ to Ce3+ causes oxygen vacancies or defects on the surface of the crystalline lattice structure of the particles, generating a cage for redox reactions to occur. The study of the chemical and biological properties of CeO2 NPs has expanded recently, and the methods used to synthesize these materials are also quite diverse. This has led to a plethora of studies describing various preparations of CeO2 NPs for potential use in both industry and for biomedical research. Our own work has centered on studies that measure the ability of water-based CeO2 NPs materials to reduce reactive oxygen and nitrogen species in biological systems, and correlating changes in surface chemistry and charge to the catalytic nature of the particles. The application in experimental and biomedical research of CeO2 NPs began with the discovery that water-based cerium oxide nanoparticles could act as superoxide dismutase mimetics followed by their ability to reduce hydrogen dioxide similar to catalase. While their ROS scavenging ability was well established, their ability to interact with specific RNS species, specifically nitric oxide (·NO) or peroxynitrite (ONOO- ) was not known. The studies described in this dissertation focus on the study of RNS and cerium oxide nanoparticles. Our in vitro work revealed that CeO2 NPs that have higher levels of reduced cerium sites (3+) at the surface (which are effective SOD mimetics) are also capable of accelerating the iv decay of peroxynitrite in vitro. In contrast, CeO2 NPs that have fewer reduced cerium sites at the particle surface (which also exhibit better catalase mimetic activity) have ·NO scavenging capabilities as well as some reactivity with peroxynitrite. Our studies and many others have shown cerium oxide nanoparticles can reduce ROS and RNS in cell culture or animal models. The accumulation of ROS and RNS is a common feature of many diseases including Alzheimer’s disease (AD). Testing our CeO2 NPS in cortical neurons, we used addition of Aβ peptide as an AD model system. CeO2 NPs delayed Aβ-induced mitochondrial fragmentation and neuronal cell death. When mitochondrial ROS levels are increased, mitochondrial fission is activated by DRP1 S616 phosphorylation. Specifically, our studies showed the reduction of phosphorylated DRP1 S616 in the presence of CeO2 NPs. Results from our studies have begun to unravel the molecule mechanism behind the catalytic nature of how CeO2 NPs reduce ROS/RNS in biological systems and represents an important step forward to test the potential neuroprotective effects of CeO2 NPs in model systems of AD. A plethora of studies describing various preparations of CeO2 NPs for potential use in both industry and for biomedical research have been described in the past five years. It has become apparent that the outcomes of CeO2 NPs exposure can vary as much as the synthesis methods and cell types tested. In an effort to understand the disparity in reports describing the toxicity or protective effects of exposure to CeO2 NPs, we compared CeO2 NPs synthesized by three different methods; H2O2 (CNP1), NH4OH (CNP2) or hexamethylenetetramine (HMT-CNP1). Exposure to HMT-CNP1 led to reduced metabolic activity (MTT) at a 10-fold lower concentration than CNP1 or CNP2 and surprisingly, exposure to HMT-CNP1 led to substantial v decreases in the ATP levels. Mechanistic studies revealed that HMT-CNP1 and CNP2 exhibited robust ATPase (phosphatase) activity, whereas CNP1 lacked ATPase activity. HMT-CNP1 were taken up into HUVECs far more efficiently than the other preparations of CeO2 NPs. Taken together, these results suggest the combination of increased uptake and ATPase activity of HMT-CNP1 may underlie the mechanism of the toxicity of this preparation of CeO2 NPs, and may suggest ATPase activity should be considered when synthesizing CeO2 NPs for use in biomedical applications. Overall the studies have uncovered two new catalytic activities for water-based CeO2 NPs (·NO scavenging and accelerated decay of peroxynitrite), demonstrated their ability to reduce RNS in an AD cell culture model as well as identifying a catalytic activity (phosphatase) that may underlie the observed toxicity of CeO2 NPs reported in other studies.

Side effects of radiation therapy (RT) remain the most challenging issue for pancreatic cancer treatment. In this report we determined whether and how cerium oxide nanoparticles (CONPs) sensitize pancreatic cancer cells to RT. CONP pretreatment enhanced radiation-induced reactive oxygen species (ROS) production preferentially in acidic cell-free solutions as well as acidic human pancreatic cancer cells. In acidic environments, CONPs favor the scavenging of superoxide radical over the hydroxyl peroxide resulting in accumulation of the latter whereas in neutral pH CONPs scavenge both. CONP treatment prior to RT markedly potentiated the cancer cell apoptosis both in culture and in tumors and the inhibition of the pancreatic tumor growth without harming the normal tissues or host mice. Mechanistically, CONPs were not able to significantly impact RT-induced DNA damage in cancer cells, thereby ruling out sensitization through increased mitotic catastrophe. However, JNK activation, which is known to be a key driver of RT-induced apoptosis, was significantly upregulated by co-treatment with CONPs and RT in pancreatic cancer cells in vitro and human pancreatic tumors in nude mice in vivo compared to CONPs or RT treatment alone. Further, CONP-driven increase in RT-induced JNK activation was associated with marked increases in Caspase 3/7 activation, indicative of apoptosis. We have shown CONPs increase ROS production in cancer cells; ROS has been shown to drive the oxidation of thioredoxin (TRX) 1 which results in the activation of Apoptosis Signaling iv Kinase (ASK) 1. The dramatic increase in ASK1 activation following the co-treatment of pancreatic cancer cells with CONPs followed by RT in vitro suggests that increased the c-Jun terminal kinase (JNK) activation is the result of increased TRX1 oxidation. The ability of CONPs to sensitize pancreatic cancer cells to RT was mitigated when the TRX1 oxidation was prevented by mutagenesis of a cysteine residue, or the JNK activation was blocked by an inhibitor,. Additionally, angiogenesis in pancreatic tumors treated with CONPs and RT was significantly reduced compared to other treatment options. Taken together, these data demonstrate an important role and mechanisms for CONPs in specifically killing cancer cells and provide novel insight into the utilization of CONPs as a radiosensitizer and therapeutic agent for pancreatic cancer.

Malignant melanoma cancer is the sixth common cancer diagnosed in the United States. Surgery, chemotherapy and radiation are some of the successful techniques in killing tumor cells. However, in these techniques, it is not easy to distinguish tumor cells from the healthy once which inadvertently get exposed to chemical agent/radiation. Therefore it is required to develop an anticancer agent which selectively kills the cancer cells, while still protecting the normal tissues. In our preliminary work, we have shown that Dextran (1000Da) coated Cerium oxide nanoparticles (Dex-CNPs) selectively kills the cancer cells (50% killing at a concentration of 150μM) without inducing toxicity to the normal cells. However, the mechanism involved on how CNPs/Dex-CNPs attain the selectivity and efficiently kill the tumor cells is still unknown. In this study we have synthesized Dextran coated ceria nano particles (Dex- CNPs) with different surface oxidation state ratio (Ce4+/Ce3+). This will provide an in depth understanding of the key chemical and physical properties of the system that can improve its efficacy. The varied surface oxidation of the particles is achieved by exposing Dex-CNPs to light which initiates a color change from dark to pale yellow indicating the reduction of Ce4+ to Ce3+. Interestingly we have found that the DexCNPs exposed to light have reduced cytotoxicity towards squamous cell carcinoma cell line (CCL30) compared to the protected once. Characterization of the same revealed that Dex- CNPs exposed to light have decreased Ce4+ /Ce3+ surface oxidation ratio compared to the other. This provides more insight in useful synthesis of Dex-CNPs in terms of storage and handling. In summary, higher Ce4+ /Ce3+ surface oxidation ratio is more efficient in hindering tumor growth by effectively hindering the tumor-stoma interaction.

The application of Cerium oxide nanoparticles (CNPs) for therapeutic purposes requires a stable dispersion of nanoparticles in biological environment. The objective of this study is to tailor the properties of polyelectrolyte coated CNPs as a function of molecular weight to achieve a stable and catalytic active dispersion. This was achieved by coating CNPs with polyacrylic acid (PAA) which increased the dispersion stability of CNPs and enhanced the catalytic ability. The stability of PAA coating was analysed using the change in the Gibbs free energy computed by Langmuir adsorption model. The adsorption isotherms were determined using soft particle electrokinetics which overcomes the challenges presented by other techniques. The Gibbs free energy was highest for PAA coated CNPs by 250 kg/mole indicating the most stable coating. The free energy for PAA 100 kg/mole coated CNPs is 85% lower than the PAA250 coated CNPs. This significant difference is caused by the strong adsorption of PAA100 on CNPs. Catalytic activity of PAA-CNPs is accessed by the catalase enzymatic activity of nanoparticles. The catalase activity was higher for PAA coated CNPs as compared to bare CNPs which indicated preferential adsorption of hydrogen peroxide induced by coating. Apart from PAA coating the catalase activity is also affected by the structure of the coating layer.

The rise of antimicrobial resistance demands the development of more rapid screening methods for the detection of antimicrobial resistance in clinical samples to both give the patient the proper treatment and expedite the treatment of patients. Cerium oxide nanoparticles may serve a useful role in diagnostics due to their ability to exist in a mixed valence state and act as either oxidizing agents or reducing agents. Considering that cerium oxide nanoparticles have been shown to shift in absorbance upon oxidation, a useful method of antimicrobial resistance detection could be based on the oxidation of cerium oxide nanoparticles. Herein, an assay is described whereby cerium oxide nanoparticle oxidation is a function of glucose metabolism of bacterial samples in the presence of an antimicrobial agent. Cerium oxide nanoparticles were shown to have an absorbance in the range of 395nm upon oxidation by hydrogen peroxide whereas mixed valence cerium oxide nanoparticles lacked an absorbance around 395nm. In the presence the hydrogen peroxide-producing glucose oxidase and either increasing concentrations of glucose or bacterial medium supplemented with increasing concentrations of glucose, cerium oxide nanoparticles were shown to increase in absorbance at 395nm. This oxidation assay was capable of measuring differences in the absorbance of E. coli and S. aureus samples grown in the presence of inhibitory and non-inhibitory concentrations of ampicillin in as little as six hours. Therefore, this cerium oxide nanoparticle oxidation assay may be very useful for use in clinical laboratories for the detection of antimicrobial resistance due to the relatively low cost, no requirement for specialized equipment and, most importantly, the reduced incubation time of the assay to as little as six hours compared to current gold standard antimicrobial resistance detection methods that require 24 hours.; This assay may thus also help partially circumvent the issue of knowledge of antimicrobial resistance in infected patients before prescribing improper regimens.